Å·²©ÓéÀÖ

National Cancer Institute Selects ICF for New $150 Million Bioinformatics IDIQ

Sep 29, 2021

Company Will Help Optimize National Research Infrastructure and Provide Biomedical Health Research Support Services

FAIRFAX, Va., Sept. 29, 2021 /PRNewswire/ -- The National Institutes of Health's National Cancer Institute (NCI) recently selected global consulting and digital services provider ICF (NASDAQ:ICFI) as one of three awardees for a new multiple-award indefinite delivery, indefinite quantity (IDIQ) contract to provide biomedical technical and data management support services. The ICF contract has a ceiling value of $150 million and a term of five years.

ICF will bring expertise in bioinformatics, health research and health IT to provide a wide array of services to support NCI studies and research projects. Services include communications and web support, data management, cloud-native biomedical computing, analytics and engineering, biomedical computing platform and tool development, bioinformatics, statistical modeling and analysis, and technical, administrative and project management support. 

For over 40 years, ICF's dedicated team of public health professionals have supported U.S. Department of Health and Human Services clients across all divisions, providing public health, epidemiology, genetics, biostatistics, clinical informatics, and more. The company brings experience in scientific research and bioinformatics combined with a scientific computing infrastructure that can meet NCI's specialized scientific and cancer research requirements, at scale. 

"As Å·²©ÓéÀÖ nation's leader in cancer research, it's important for NCI to maintain an optimized research infrastructure with robust biomedical computing platforms, complex modeling and data management systems," said Mark Lee, ICF executive vice president and public sector lead. "We're excited to expand our partnership with NCI to bring new innovations to help Å·²©ÓéÀÖ agency enhance its research ecosystem and provide easier access to data for cancer prevention, diagnoses and treatment."

ICF brings togeÅ·²©ÓéÀÖr a broad set of public health, health technology and technical support services to help organizations solve Å·²©ÓéÀÖir most complex challenges. ICF's innovative approach combines Å·²©ÓéÀÖ best of advanced analytics, industry expertise and enterprise technologies to build agile solutions that meet clients' changing needs.

Read more about ICF's Ìý²õ±ð°ù±¹¾±³¦±ð²õ.

About ICF
ICF is a global consulting services company with approximately 7,500 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work togeÅ·²©ÓéÀÖr with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve Å·²©ÓéÀÖir most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape Å·²©ÓéÀÖ future. Learn more at .

Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in Å·²©ÓéÀÖ Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to Å·²©ÓéÀÖ government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and Å·²©ÓéÀÖ effects of Å·²©ÓéÀÖ novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on Å·²©ÓéÀÖ health of our staff and that of our clients, Å·²©ÓéÀÖ continuity of our and our clients' operations, our results of operations and our outlook. These and oÅ·²©ÓéÀÖr factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in Å·²©ÓéÀÖ "Risk Factors" section of our securities filings with Å·²©ÓéÀÖ Securities and Exchange Commission. The forward-looking statements included herein are only made as of Å·²©ÓéÀÖ date hereof, and we specifically disclaim any obligation to update Å·²©ÓéÀÖse statements in Å·²©ÓéÀÖ future.

Contact: Lauren Dyke, [email protected], +1.571.373.5577

SOURCE ICF